Header cover image

Brazilian Pharmaceuticals & Biotech Price disconnect

Results

1

1 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

1 companies

Hypera

Market Cap: R$15.1b

Operates as a pharmaceutical company in Brazil.

New

HYPE3

R$21.44

7D

5.6%

1Y

-17.7%